Atlas Trials

SAFE-iPS - France's First Hospital-based Platform for the Production of Induced Pluripotent Stem Cells for the Regenerative Medicine of the Future

Clinical trial NCT07735559 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07735559
Sponsor
University Hospital, Montpellier
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Regenerative MedicineInduced Pluripotent Stem Cells (iPSC) Production
Start date
2026-11-01
Primary completion
2027-11-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.